MedTrace Logo

Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects

NCT03293693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2017-09-26

No results posted yet for this study

Summary

The overall aim is to investigate the intake of beta-glucan in relation to glucose metabolism and satiety in a postprandial study with healthy subjects. The potential effects will be related to changes in the gut microbiota, the circulating levels of short chain fatty acids, inflammation and gene expression in peripheral mononuclear blood cells

Conditions

  • Post Prandial Blood Glucose
  • Gut Microbiota
  • Satiety

Interventions

OTHER

0.5 g beta-glucan

Dietary cross-over study with beta-glucan fiber

OTHER

3.5 g beta-glucan

Dietary cross-over study with beta-glucan fiber

OTHER

8 g beta-glucan

Dietary cross-over study with beta-glucan fiber

Sponsors & Collaborators

  • Mills DA

    collaborator INDUSTRY

  • Nofima

    collaborator OTHER

  • University of Oslo

    collaborator OTHER

  • Oslo Metropolitan University

    lead OTHER

Principal Investigators

  • Mari CW Myhrstad, PhD · Oslo and Akershus University College

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03293693 on ClinicalTrials.gov